
Bulk bill incentive could miss thousands of GP clinics
Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800.
But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics.
Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed.
"This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement.
"For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient."
From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness.
The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution.
"The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said.
It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change.
Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said.
The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none.
A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns.
Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800.
But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics.
Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed.
"This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement.
"For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient."
From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness.
The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution.
"The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said.
It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change.
Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said.
The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none.
A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns.
Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800.
But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics.
Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed.
"This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement.
"For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient."
From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness.
The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution.
"The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said.
It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change.
Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said.
The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none.
A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns.
Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800.
But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics.
Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed.
"This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement.
"For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient."
From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness.
The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution.
"The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said.
It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change.
Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said.
The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


West Australian
14 hours ago
- West Australian
World-first study could provide MS breakthrough
A world-first study aims to identify a person's genetic risk of developing multiple sclerosis by using their DNA. The research will investigate why some people develop MS and others don't, even if they are exposed to the same common virus. University of South Australia's David Stacey told AAP the pilot study would involve an innovative approach, called "recall by genotype", which has never been used in MS research. "It's like studying the immune system's blueprint before the disease starts," said Dr Stacey, who leads the study. As the most common acquired chronic neurological disease affecting young adults, MS impacts more than 33,000 Australians. Symptoms can include loss of motor function, loss of sensation, pain, vision changes and changes to thinking and memory. While there is no cure or single known cause for MS, many genetic and environmental factors are believed to contribute to its development. Dr Stacey says the study will select two groups of participants based on whether they have a high or low genetic risk of MS. By comparing the groups, researchers hope to understand how their immune systems respond to the Epstein-Barr virus, a disease that causes glandular fever and has been strongly linked to MS. While most people get infected with Epstein-Barr virus, only a small number develop MS. Researchers believe differences in how a person's immune system reacts to the virus might explain why some people get MS and others don't. "It could also help identify early biological markers that show when MS might be starting to develop. This may lead to earlier detection, new treatments or even prevention," Dr Stacey said. "We want to take learnings from this to help inform a larger, more scaled-up version of this study." The research is funded through MS Australia's latest Incubator Grant round, which supports ideas aimed at opening new directions in MS research. "Our mission is to accelerate research and improve outcomes for every person living with MS," chief executive Rohan Greenland said.


Perth Now
14 hours ago
- Perth Now
World-first study could provide MS breakthrough
A world-first study aims to identify a person's genetic risk of developing multiple sclerosis by using their DNA. The research will investigate why some people develop MS and others don't, even if they are exposed to the same common virus. University of South Australia's David Stacey told AAP the pilot study would involve an innovative approach, called "recall by genotype", which has never been used in MS research. "It's like studying the immune system's blueprint before the disease starts," said Dr Stacey, who leads the study. As the most common acquired chronic neurological disease affecting young adults, MS impacts more than 33,000 Australians. Symptoms can include loss of motor function, loss of sensation, pain, vision changes and changes to thinking and memory. While there is no cure or single known cause for MS, many genetic and environmental factors are believed to contribute to its development. Dr Stacey says the study will select two groups of participants based on whether they have a high or low genetic risk of MS. By comparing the groups, researchers hope to understand how their immune systems respond to the Epstein-Barr virus, a disease that causes glandular fever and has been strongly linked to MS. While most people get infected with Epstein-Barr virus, only a small number develop MS. Researchers believe differences in how a person's immune system reacts to the virus might explain why some people get MS and others don't. "It could also help identify early biological markers that show when MS might be starting to develop. This may lead to earlier detection, new treatments or even prevention," Dr Stacey said. "We want to take learnings from this to help inform a larger, more scaled-up version of this study." The research is funded through MS Australia's latest Incubator Grant round, which supports ideas aimed at opening new directions in MS research. "Our mission is to accelerate research and improve outcomes for every person living with MS," chief executive Rohan Greenland said.

The Australian
15 hours ago
- The Australian
Albanese government praises ‘critical' program in teen vape fight
The Albanese government is celebrating after a key study found an anti-vaping program is helping curb the spike in fuming teens. A randomised controlled trial involving some 5000 students from 40 schools found participants were 65 per cent less likely to vape after 12 months when compared to students who did not take part in the program. The findings were published on Tuesday in the world leading health journal, The Lancet. Health Minister Mark Butler praised the results, calling the program 'a critical part of our vaping strategy'. Health Minister Mark Butler has praised the results of a clinical trial that found. Picture: Martin Ollman / NewsWire 'Vaping rates exploded, especially in the last five years, literally exploded year on year,' Mr Butler told reporters at Parliament House, flanked by students. 'This was sold to countries around the world as a therapeutic good that would allow hardened smokers, usually in middle age, to kick the habit if other attempts to kick smoking had not worked. 'But what we found relatively quickly was this was quite a different strategy by big tobacco. 'It was a strategy to recruit a new generation to nicotine addiction.' He said he was 'delighted we have been able to fund' the program, run by the Our Futures Institute. Under the program, students learn about the harms of vaping through visual stories and game-like activities, such as quizzes. Health Minister Mark Butler says 'big tobacco' was trying to lure in Australian teenagers. Picture: Martin Ollman / NewsWire In 2019, 9.6 per cent of teens aged 14-17 were estimated to have used vapes, according to official data. It nearly tripled to 28 per cent by 2023. Earlier this year, the Albanese government said numbers the numbers were falling after a series of measures aimed at curbing the uptake among young Australians. Among the measures were banning single-use vapes. According data put out in January, vaping rates for Australian 15 and had fallen more than a third since 2023. The data also showed the number of 'never-vapers' among 14-17-year-olds had reached a record high of 85 per cent.